The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer: Experience from a safety-net hospital serving a racially and ethnically diverse patient population.
 
Alyssa Liang
No Relationships to Disclose
 
Heidi Dowst
No Relationships to Disclose
 
Neda Zarrin-Khameh
No Relationships to Disclose
 
Quillan Huang
Stock and Other Ownership Interests - Merck
 
Attiya Batool Noor
No Relationships to Disclose
 
Guilherme Godoy
No Relationships to Disclose
 
Patricia Castro
No Relationships to Disclose
 
Michael E. Scheurer
No Relationships to Disclose
 
Susan G. Hilsenbeck
No Relationships to Disclose
 
Martha P. Mims
Stock and Other Ownership Interests - Amgen; Biogen
Research Funding - AVEO (Inst); Celgene; Pfizer (Inst)
 
Nicholas Mitsiades
Research Funding - Tempus (Inst)